Figure 2.
The association between the MIF -173G/C polymorphism and gastrointestinal cancer and hematological malignancy risk (CC+CG vs. GG).
The association between the MIF -173G/C polymorphism and gastrointestinal cancer and hematological malignancy risk (CC+CG vs. GG).